Allos AI Secures $5 Million to Innovate Drug Reformulation Using Causal AI Allos AI has acquired $5 million in funding to drive the commercial use of its groundbreaking Causal AI platform, revolutionizing drug reformulation processes.

Allos AI Secures $5 Million to Innovate Drug Reformulation Using Causal AI #United_Kingdom #Oxford #Causal_AI #Allos_AI #drug_reformulation